| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flows from financing activities | 14,238 | 12,942 |
| Net (decrease)/increase in cash and cash equivalents | -3,595 | -1,349 |
| Cash and cash equivalents at beginning of period | 15,120 | - |
| Cash and cash equivalents at end of period | 11,525 | - |
GALECTIN THERAPEUTICS INC (GALT)
GALECTIN THERAPEUTICS INC (GALT)